PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+8.31%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(-14%)
Cap. Flow
-$66.6M
Cap. Flow
% of AUM
-16.84%
Top 10 Holdings %
Top 10 Hldgs %
40.77%
Holding
93
New
11
Increased
18
Reduced
29
Closed
19
Top Buys
| 1 |
AbbVie
ABBV
|
$8.09M |
| 2 |
Fulcrum Therapeutics
FULC
|
$5.43M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.67M |
| 4 |
Immunic
IMUX
|
$4.51M |
| 5 |
Amgen
AMGN
|
$4.25M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$18M |
| 2 |
Charles River Laboratories
CRL
|
$11.2M |
| 3 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$7.96M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$5.93M |
Sector Composition
| 1 | Healthcare | 97.83% |
| 2 | Industrials | 0.81% |
| 3 | Technology | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DexCom
DXCM
$29.5B
| $24.9M | 6.29% | 45,458 -5,000 | -10% | -$2.73M |
|
2
Aclaris Therapeutics
ACRS
$209M
| $23.5M | 5.95% | 1,306,460 -195,000 | -13% | -$3.51M |
|
3
Avantor
AVTR
$9.18B
| $18M | 4.55% | 440,000 +86,059 | +24% | +$3.52M |
|
4
United Therapeutics
UTHR
$13.8B
| $17.4M | 4.4% | 94,324 | – | – |
|
5
IQVIA
IQV
$32.4B
| $16.7M | 4.23% | 69,869 +1,500 | +2% | +$359K |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $14.2M | 3.58% | 74,967 | – | – |
|
7
Danaher
DHR
$147B
| $13.8M | 3.49% | 45,324 -10,500 | -19% | -$3.2M |
|
|
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.3M | 3.12% | 72,676 +27,500 | +61% | +$4.67M |
|
|
9
Charles River Laboratories
CRL
$8.04B
| $10.3M | 2.61% | 25,000 -27,245 | -52% | -$11.2M |
|
10
Natera
NTRA
$23.1B
| $10M | 2.54% | 90,047 -30,500 | -25% | -$3.4M |
|
11
Cooper Companies
COO
$13.4B
| $9.96M | 2.52% | 24,088 +5,500 | +30% | +$2.27M |
|
12
Gossamer Bio
GOSS
$562M
| $9.89M | 2.5% | 786,870 | – | – |
|
13
Insulet
PODD
$23.9B
| $9.76M | 2.47% | 34,340 -1,000 | -3% | -$284K |
|
|
CDMO
14
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $9.71M | 2.46% | 450,000 -25,000 | -5% | -$539K |
|
|
15
Fulcrum Therapeutics
FULC
$351M
| $9.56M | 2.42% | 338,796 +192,407 | +131% | +$5.43M |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.74M | 2.21% | 79,767 +7,500 | +10% | +$822K |
|
17
Arcus Biosciences
RCUS
$1.13B
| $8.25M | 2.09% | 236,637 -10,000 | -4% | -$349K |
|
|
18
Immunic
IMUX
$80.9M
| $8.18M | 2.07% | 924,087 +510,000 | +123% | +$4.51M |
|
|
19
AbbVie
ABBV
$372B
| $8.09M | 2.05% | +75,000 | New | +$8.09M |
|
|
APEN
20
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.53M | 1.91% | 831,214 +140,000 | +20% | +$1.27M |
|
21
Humana
HUM
$36.5B
| $7.39M | 1.87% | 19,000 -13,681 | -42% | -$5.32M |
|
22
Codexis
CDXS
$246M
| $6.65M | 1.68% | 286,067 +80,000 | +39% | +$1.86M |
|
23
Repligen
RGEN
$6.88B
| $5.78M | 1.46% | 20,000 -18,740 | -48% | -$5.42M |
|
|
CTLT
24
DELISTED
CATALENT, INC.
CTLT
| $5.29M | 1.34% | 39,739 -15,000 | -27% | -$2M |
|
25
Idexx Laboratories
IDXX
$51.8B
| $4.77M | 1.21% | 7,667 | – | – |
|